Antidepressants and the FDA’s Black-Box Warning: Determining a Rational Public Policy in the Absence of Sufficient Evidence https://t.co/3x21b38XVq via @journalofethics
A 2004 decision by the FDA to place a "black box warning" on a number of antidepressants was made with seemingly sparse evidence. What ought a regulatory agency do when a public policy decision must be made in the absence of quality evidence? https://t.co/
@cnmmedic @CapitalistFraud The data Cochrane used is poor because drug companies have not co-operated. Interesting paper: https://t.co/QosQmdX0eG So it's down to your own hunch apparently! But why bother?